Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 9Lymphoma, Follicular 4Recurrence 3Lymphoma, B-Cell 3Neoplasms, Plasma Cell 2Burkitt Lymphoma 2Spondylolisthesis 1Spinal Stenosis 1Spinal Cord Neoplasms 1Smoldering Multiple Myeloma 1Neoplasms 1Neoplasm, Residual 1Meningeal Carcinomatosis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Lymphedema 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Intervertebral Disc Displacement 1Intervertebral Disc Degeneration 1Hodgkin Disease 1Failed Back Surgery Syndrome 1Disease Progression 1Disease 1Breast Neoplasms 1Bone Neoplasms 1

Interventions

Tretinoin 27Arsenic Trioxide 27Cytarabine 20Cyclophosphamide 14Methotrexate 13Idarubicin 13Busulfan 11Filgrastim 10Etoposide 8fludarabine phosphate 7Peripheral Blood Stem Cell Transplantation 7Mercaptopurine 7Gemtuzumab 7Daunorubicin 7Radiotherapy 6Tacrolimus 5Mitoxantrone 5Clofarabine 5Vorinostat 4Topotecan 4Sorafenib 4Antilymphocyte Serum 4Mycophenolic Acid 3Granulocyte Colony-Stimulating Factor 3Bortezomib 3Azacitidine 3venetoclax 2tamibarotene 2sargramostim 2romidepsin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Promyelocytic, Acute × Transplantation, Autologous × Clear all
NCT00504764 2014-10-28

Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

PETHEMA Foundation

Phase 4 Completed
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡